Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients

NCT02473328 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: Atazanavir 200 mg/r

Sponsor

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida

Collaborators

[object Object]